Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Decreases By 66.7%

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,000 shares, a drop of 66.7% from the February 28th total of 3,000 shares. Currently, 0.0% of the company's shares are short sold. Based on an average trading volume of 109,300 shares, the short-interest ratio is presently 0.0 days.

Sysmex Trading Down 1.6 %

SSMXY traded down $0.30 during trading hours on Monday, reaching $18.85. 58,485 shares of the company's stock traded hands, compared to its average volume of 67,435. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. The firm has a 50-day moving average price of $18.61 and a 200 day moving average price of $19.09. Sysmex has a 52-week low of $14.38 and a 52-week high of $28.32. The firm has a market capitalization of $11.87 billion, a PE ratio of 36.87 and a beta of 0.88.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The company reported $0.17 EPS for the quarter. As a group, sell-side analysts predict that Sysmex will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.